Phreesia, Inc. (NYSE:PHR) COO Evan Roberts Sells 2,681 Shares

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 2,681 shares of the stock in a transaction on Wednesday, January 8th. The stock was sold at an average price of $27.95, for a total value of $74,933.95. Following the completion of the transaction, the chief operating officer now owns 769,993 shares in the company, valued at approximately $21,521,304.35. This represents a 0.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Evan Roberts also recently made the following trade(s):

• On Monday, January 6th, Evan Roberts sold 2,873 shares of Phreesia stock. The shares were sold at an average price of $26.61, for a total transaction of $76,450.53.
• On Tuesday, October 15th, Evan Roberts sold 1,843 shares of Phreesia stock. The stock was sold at an average price of $21.03, for a total transaction of $38,758.29.

Phreesia Stock Performance

NYSE:PHR opened at $26.75 on Friday. The company has a market capitalization of $1.55 billion, a P/E ratio of -18.20 and a beta of 0.94. The business has a fifty day simple moving average of $22.87 and a two-hundred day simple moving average of $22.63. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. The firm’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same quarter last year, the firm posted ($0.58) EPS. On average, analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC boosted its holdings in Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after buying an additional 1,395 shares during the period. Lombard Odier Asset Management USA Corp bought a new position in shares of Phreesia in the second quarter worth $202,000. Point72 DIFC Ltd purchased a new position in shares of Phreesia in the second quarter valued at $209,000. XTX Topco Ltd bought a new stake in shares of Phreesia during the 3rd quarter valued at $247,000. Finally, Hsbc Holdings PLC purchased a new stake in Phreesia during the 2nd quarter worth about $301,000. Institutional investors own 92.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on PHR shares. Needham & Company LLC reissued a “buy” rating and set a $29.00 price objective on shares of Phreesia in a report on Friday. JMP Securities reissued a “market outperform” rating and issued a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. KeyCorp lifted their price objective on shares of Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a report on Wednesday. Royal Bank of Canada upgraded shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a report on Wednesday. Finally, Truist Financial boosted their price target on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia presently has a consensus rating of “Buy” and a consensus target price of $31.00.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.